RT @MPishvaian
#TumorBoardTuesday #GI23Dr. Moehler presented a Ph3 trial demonstrating that chemo
tiselizumab
mOS over chemo alone in gastric/GE Jx Cancer
mOS was improved by 4.5 months
BUT....how are you going to choose
Chemo + nivo
orChemo + tisle